Efficacy and safety of Trifluridin/Tipiracil (FTD/TPI) (Lonsurf (R)) in patients with metastatic colorectal cancer (CRC) in clinical-routine use

Cao J, Wiesweg M, Fuchs M, Stein A, Karthaus M, Lettmaier S, Kretzschmar A, Draube A, Ettrich T, Ruessel J, Mueller C, Rafiyan MR, Borchert K, Schuler M, Kasper S (2018)

Publication Type: Conference contribution

Publication year: 2018

Journal

Oncology Research and Treatment Karger Publishers

Book Volume: 41

Pages Range: 289-289

Involved external institutions

Städtisches Klinikum München

Germany (DE) Carl-von-Basedow-Klinikum Saalekreis

Germany (DE) Universitätsklinikum Ulm

Germany (DE) Kliniken Essen-Mitte

Germany (DE) Klinikum Magdeburg

Germany (DE) Krankenhaus Nordwest

Germany (DE) Universitätsklinikum Hamburg-Eppendorf (UKE)

Germany (DE) Universitätsklinikum Essen

Germany (DE) Klinikum Harlaching

Germany (DE)

How to cite

APA:

Cao, J., Wiesweg, M., Fuchs, M., Stein, A., Karthaus, M., Lettmaier, S.,... Kasper, S. (2018). Efficacy and safety of Trifluridin/Tipiracil (FTD/TPI) (Lonsurf (R)) in patients with metastatic colorectal cancer (CRC) in clinical-routine use. (pp. 289-289).

MLA:

Cao, J., et al. "Efficacy and safety of Trifluridin/Tipiracil (FTD/TPI) (Lonsurf (R)) in patients with metastatic colorectal cancer (CRC) in clinical-routine use." 2018. 289-289.

BibTeX: Download